封面
市場調查報告書
商品編碼
1386278

即時照護 (POCT) 市場報告:2030 年趨勢、預測與競爭分析

Point-of-Care (POCT) Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

即時照護 (POCT) 趨勢與預測

到 2030 年,全球定點醫療 (POCT) 市場預計將達到 700 億美元,2024 年至 2030 年年複合成長率為 10.3%。該市場的主要驅動力是對疾病早期診斷和治療的需求不斷成長、遠端醫療和遠距醫療保健服務的日益採用以及對負擔得起且易於使用的即時檢測設備的需求不斷成長。全球即時照護 (POCT) 市場的未來前景廣闊,醫院、診斷中心、實驗室和居家醫療環境市場都充滿機會。

照護端 (POCT) 市場洞察

Lucintel 預測,由於血糖值測試的便利性、易用性以及在家中或醫療保健環境中進行的能力,血糖測試將在預測期內實現最高成長。

預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和業務風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球即時照護 (POCT) 市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球即時照護 (POCT) 市場趨勢(2018-2023)和預測(2024-2030)
  • 按產品類型分類的全球照護端 (POCT) 市場
    • 血糖監測
    • 儀表
    • 柳葉刀
    • 心臟代謝測試
    • 心臟標記測試
    • 其他
  • 按技術分類的全球照護端 (POCT) 市場
    • 側流層析
    • 量油尺
    • 微流體學
    • 分子診斷
    • 免疫學測試
    • 凝集試驗
    • 流經
    • 固相
    • 生物感測器
  • 按應用分類的全球照護端 (POCT) 市場
    • 心臟代謝測試
    • 傳染病檢查
    • 腎臟病學測試
    • 藥物濫用測試
    • 血糖測試
    • 懷孕測試
    • 癌症生物標記測試
    • 其他
  • 按最終用途分類的全球照護端 (POCT) 市場
    • 醫院
    • 診斷中心
    • 調查
    • 家庭護理設置
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球照護端 (POCT) 市場
  • 北美即時護理 (POCT) 市場
  • 歐洲即時護理 (POCT) 市場
  • 亞太地區照護端 (POCT) 市場
  • 其他地區的即時護理(POCT)市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球照護端 (POCT) 市場成長機會
    • 全球即時護理 (POCT) 市場成長機會(按技術)
    • 全球照護端 (POCT) 市場成長機會(按應用)
    • 按最終用途分類的全球照護端 (POCT) 市場成長機會
    • 按地區分類的全球照護端 (POCT) 市場成長機會
  • 全球即時護理 (POCT) 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球即時護理 (POCT) 市場的產能
    • 全球即時護理 (POCT) 市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott
  • F. Hoffmann-La Roche
  • BD
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics
簡介目錄

Point-of-Care (POCT) Trends and Forecast

The future of the global point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets. The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

A more than 150-page report is developed to help in your business decisions.

Point-of-Care (POCT) by Segment

The study includes a forecast for the global point-of-care (POCT) by product type, technology, application, end use, and region.

Point-of-Care (POCT) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Glucose Monitoring
  • Strips
  • Meters
  • Lancets
  • Cardiometabolic Testing
  • Cardiac Marker Testing
  • Others

Point-of-Care (POCT) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Agglutination Assays
  • Flow-Through
  • Solid Phase
  • Biosensors

Point-of-Care (POCT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardio Metabolic Testing
  • Infectious Disease Testing
  • Nephrology Testing
  • Drug-of-Abuse Testing
  • Blood Glucose Testing
  • Pregnancy Testing
  • Cancer Biomarker Testing
  • Others

Point-of-Care (POCT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Home-Care Settings
  • Others

Point-of-Care (POCT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Point-of-Care (POCT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care (POCT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care (POCT) companies profiled in this report include-

  • Abbott
  • F. Hoffmann-La Roche
  • B.D.
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics

Point-of-Care (POCT) Market Insights

Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

North America is expected to witness highest growth over the forecast period.

Features of the Global Point-of-Care (POCT) Market

Market Size Estimates: Point-of-care (POCT) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Point-of-care (POCT) market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Point-of-care (POCT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the point-of-care (POCT) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care (POCT) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the point-of-care (POCT) market size?

Answer: The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030.

Q.2 What is the growth forecast for point-of-care (POCT) market?

Answer: The global point-of-care (POCT) market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the point-of-care (POCT) market?

Answer: The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

Q4. What are the major segments for point-of-care (POCT) market?

Answer: The future of the point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets.

Q5. Who are the key point-of-care (POCT) market companies?

Answer: Some of the key point-of-care (POCT) companies are as follows:

  • Abbott
  • F. Hoffmann-La Roche
  • B.D.
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics

Q6. Which point-of-care (POCT) market segment will be the largest in future?

Answer: Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

Q7. In point-of-care (POCT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the point-of-care (POCT) market by product type (glucose monitoring, strips, meters, lancets, cardiometabolic testing, cardiac marker testing, and others), technology (lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, agglutination assays, flow-through, solid phase, and biosensors), application (cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse testing, blood glucose testing, pregnancy testing, cancer biomarker testing, and others), end use (hospitals, diagnostic centers, research laboratories, home-care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Point-of-Care (POCT) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Point-of-Care (POCT) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Point-of-Care (POCT) Market by Product Type
    • 3.3.1: Glucose Monitoring
    • 3.3.2: Strips
    • 3.3.3: Meters
    • 3.3.4: Lancets
    • 3.3.5: Cardiometabolic Testing
    • 3.3.6: Cardiac marker Testing
    • 3.3.7: Others
  • 3.4: Global Point-of-Care (POCT) Market by Technology
    • 3.4.1: Lateral Flow Assays
    • 3.4.2: Dipsticks
    • 3.4.3: Microfluidics
    • 3.4.4: Molecular Diagnostics
    • 3.4.5: Immunoassays
    • 3.4.6: Agglutination Assays
    • 3.4.7: Flow-Through
    • 3.4.8: Solid Phase
    • 3.4.9: Biosensors
  • 3.5: Global Point-of-Care (POCT) Market by Application
    • 3.5.1: Cardio Metabolic Testing
    • 3.5.2: Infectious Disease Testing
    • 3.5.3: Nephrology Testing
    • 3.5.4: Drug-of-Abuse Testing
    • 3.5.5: Blood Glucose Testing
    • 3.5.6: Pregnancy Testing
    • 3.5.7: Cancer Biomarker Testing
    • 3.5.8: Others
  • 3.6: Global Point-of-Care (POCT) Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Diagnostic Centers
    • 3.6.3: Research Laboratories
    • 3.6.4: Home-Care Settings
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Point-of-Care (POCT) Market by Region
  • 4.2: North American Point-of-Care (POCT) Market
    • 4.2.1: North American Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.2.2: North American Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.3: European Point-of-Care (POCT) Market
    • 4.3.1: European Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.3.2: European Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.4: APAC Point-of-Care (POCT) Market
    • 4.4.1: APAC Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.4.2: APAC Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.5: ROW Point-of-Care (POCT) Market
    • 4.5.1: ROW Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.5.2: ROW Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Point-of-Care (POCT) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Point-of-Care (POCT) Market by Technology
    • 6.1.3: Growth Opportunities for the Global Point-of-Care (POCT) Market by Application
    • 6.1.4: Growth Opportunities for the Global Point-of-Care (POCT) Market by End Use
    • 6.1.5: Growth Opportunities for the Global Point-of-Care (POCT) Market by Region
  • 6.2: Emerging Trends in the Global Point-of-Care (POCT) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Point-of-Care (POCT) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Point-of-Care (POCT) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: F. Hoffmann-La Roche
  • 7.3: B.D.
  • 7.4: Siemens Healthcare
  • 7.5: Bio-Rad Laboratories
  • 7.6: Danaher
  • 7.7: Sekisui Diagnostics